CN111588648A - Autophagy rejuvenation anti-aging cream - Google Patents
Autophagy rejuvenation anti-aging cream Download PDFInfo
- Publication number
- CN111588648A CN111588648A CN202010438855.8A CN202010438855A CN111588648A CN 111588648 A CN111588648 A CN 111588648A CN 202010438855 A CN202010438855 A CN 202010438855A CN 111588648 A CN111588648 A CN 111588648A
- Authority
- CN
- China
- Prior art keywords
- phase
- parts
- autophagy
- stirring
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004900 autophagic degradation Effects 0.000 title claims abstract description 25
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 23
- 239000006071 cream Substances 0.000 title claims abstract description 23
- 230000003716 rejuvenation Effects 0.000 title claims abstract description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229940081733 cetearyl alcohol Drugs 0.000 claims abstract description 14
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 14
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 10
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 10
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 10
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229930006000 Sucrose Natural products 0.000 claims abstract description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 9
- 229940074979 cetyl palmitate Drugs 0.000 claims abstract description 9
- 229930182478 glucoside Natural products 0.000 claims abstract description 9
- 150000008131 glucosides Chemical class 0.000 claims abstract description 9
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000005720 sucrose Substances 0.000 claims abstract description 9
- 229930003799 tocopherol Natural products 0.000 claims abstract description 9
- 229960001295 tocopherol Drugs 0.000 claims abstract description 9
- 239000011732 tocopherol Substances 0.000 claims abstract description 9
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 9
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 5
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 5
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims abstract description 5
- 229940078812 myristyl myristate Drugs 0.000 claims abstract description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 5
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 5
- 229940057910 shea butter Drugs 0.000 claims abstract description 5
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 claims abstract description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 5
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000000284 extract Substances 0.000 claims description 36
- 238000003756 stirring Methods 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 239000008367 deionised water Substances 0.000 claims description 16
- 229910021641 deionized water Inorganic materials 0.000 claims description 16
- 230000003020 moisturizing effect Effects 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 12
- 230000003750 conditioning effect Effects 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 4
- 244000186892 Aloe vera Species 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 4
- 244000241838 Lycium barbarum Species 0.000 claims description 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 241000246044 Sophora flavescens Species 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- 235000011399 aloe vera Nutrition 0.000 claims description 4
- 229960001631 carbomer Drugs 0.000 claims description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 4
- 235000010418 carrageenan Nutrition 0.000 claims description 4
- 229940074992 chondrus crispus extract Drugs 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 239000003974 emollient agent Substances 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 238000000265 homogenisation Methods 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 4
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 4
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 230000002087 whitening effect Effects 0.000 claims description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 3
- 240000004638 Dendrobium nobile Species 0.000 claims 1
- 240000004530 Echinacea purpurea Species 0.000 claims 1
- 239000004909 Moisturizer Substances 0.000 claims 1
- 235000014134 echinacea Nutrition 0.000 claims 1
- 230000001333 moisturizer Effects 0.000 claims 1
- 238000004945 emulsification Methods 0.000 abstract description 4
- 239000003999 initiator Substances 0.000 abstract description 4
- 239000004973 liquid crystal related substance Substances 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 17
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 6
- 229930186217 Glycolipid Natural products 0.000 description 6
- 238000010586 diagram Methods 0.000 description 4
- 210000002706 plastid Anatomy 0.000 description 4
- 241001523681 Dendrobium Species 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000020694 echinacea extract Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 102000009091 Amyloidogenic Proteins Human genes 0.000 description 2
- 108010048112 Amyloidogenic Proteins Proteins 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000007320 autophagy mechanism Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 229940048300 coco-caprylate Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical group CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses an autophagy rejuvenation anti-aging cream which is characterized by comprising a phase A, a phase B, a phase C, a phase D, a phase E and a phase F, wherein the phase A comprises 1 part of sucrose polystearate and cetyl palmitate, 2.5 parts of cetearyl glucoside and cetearyl alcohol, 3 parts of propylene glycol and 2 parts of cetearyl alcohol, and the phase B comprises 6 parts of triglyceride, 3 parts of coco-caprylate/caprate, 2 parts of hydrogenated polyisobutene, 1 part of polydimethylsiloxane, 3 parts of shea butter, 1 part of myristyl myristate and 0.5 part of tocopherol; according to the invention, the trehalose is wrapped by adding the autophagy initiator to wrap nutritional ingredients such as trehalose through a liquid crystal type emulsification system, and the autophagy rejuvenation anti-aging cream of the anti-aging skin care product of the autophagy initiator is prepared through a liquid crystal type emulsification step.
Description
Technical Field
The invention relates to the technical field, in particular to an autophagy rejuvenation anti-aging cream.
Background
With the increase of the pace of life, the aging speed of human skin is greatly increased, resulting in dry skin and uneven complexion. However, in the prior art, the formula is rarely directed to skin care products which activate the autophagy mechanism of the human body, and the autophagy of the skin is a natural process, and the detoxification process of continuously degrading and continuously updating damaged cell components is adopted, so that the autophagy rejuvenation anti-aging cream is urgently needed to be designed to solve the problems.
Disclosure of Invention
The invention aims to solve the defects in the prior art and provides an autophagy skin-refreshing anti-aging cream.
In order to achieve the purpose, the invention adopts the following technical scheme:
an autophagy whitening anti-aging cream is characterized by comprising a phase A, a phase B, a phase C, a phase D, a phase E and a phase F, wherein the phase A comprises 1 part of sucrose polystearate and cetyl palmitate, 2.5 parts of cetearyl glucoside and cetearyl alcohol, 3 parts of propylene glycol and 2 parts of cetearyl alcohol, the phase B comprises 6 parts of triglyceride, 3 parts of coco-caprylate/caprate, 2 parts of hydrogenated polyisobutene, 1 part of polydimethylsiloxane, 3 parts of shea butter, 1 part of myristyl myristate and 0.5 part of tocopherol, the phase C comprises 0.2 part of sodium polyacrylate, 4 parts of glycerol, 2 parts of butanediol and 5 parts of 1, 2-pentanediol, the phase D comprises 52.8 parts of deionized water and 5 parts of a moisturizing extract, the phase E comprises 0.2 part of carboxymethyl chitosan and 3 parts of deionized water, and the phase F comprises 5 parts of a conditioning extract and 3 parts of deionized water, the conditioning extract comprises water, butylene glycol, trehalose, hydrogenated lecithin, carbomer, and Chondrus crispus extract.
Further, the moisturizing extract comprises water, glycerin, stem extract of dendrobium stem, leaf extract of aloe vera, root extract of sophora flavescens ait, fruit extract of lycium barbarum and echinacea extract.
Further, sucrose polystearate and cetyl palmitate, cetearyl glucoside and cetearyl alcohol of the phase a are used as emulsifiers.
Further, the tocopherol of phase B is primarily vitamin E acting as a skin conditioner, with the remainder being emollients.
Further, the deionized water of the phase D is used as a solvent to mix the moisturizing extracts into the moisturizing agent.
The manufacturing process comprises the following steps:
respectively heating the S1 phase and the C A, B phase to mix, heating the C phase, adding the C phase into the A, B phase mixed solution, and fully stirring until the components are uniformly dispersed;
s2, adding the phase B into the phase A in a water bath kettle, and uniformly stirring; cooling to 55 ℃;
s3, adding the phase C into the phase A + phase B in a water bath kettle under the condition of continuously stirring, stirring and mixing uniformly, stirring and dispersing uniformly, homogenizing, and then cooling and stirring;
and S4, cooling to 40 ℃, adding the phase D, the phase E and the phase F, stirring and dispersing uniformly until the temperature is room temperature, and filling.
Further, the A, B phases were mixed and heated to 80 ℃ and the C phase was heated to 55 ℃.
Further, the homogenization speed of stirring in S3 is 8000, and stirring is performed for 20 min.
The invention has the beneficial effects that:
1. the autophagy rejuvenation anti-aging cream is prepared by wrapping trehalose and other nutritional ingredients by adding an autophagy initiator through a liquid crystal type emulsification system and performing a liquid crystal type emulsification step to prepare the autophagy rejuvenation anti-aging cream which wraps the trehalose and plays a role in anti-aging skin care products of the autophagy initiator.
2. The invention can eliminate the amyloid protein expression (a skin aging index) on human skin, so as to improve the skin color uniformity, moisten the cuticle, and improve the size and the visible degree of the fishtail line.
Drawings
Fig. 1 is a schematic structural view of an autophagy rejuvenation anti-aging cream provided by the present invention;
fig. 2 is a schematic diagram of CPD damage of the autophagy rejuvenation anti-aging cream provided by the present invention;
fig. 3 is a schematic diagram of 8OHdG lesions of the autophagy rejuvenation anti-aging cream provided by the present invention;
fig. 4 is a schematic diagram of CP damage of an autophagy rejuvenation anti-aging cream according to the present invention;
FIG. 5 is a graph of the reduction of pigmentation following UVB irradiation of algal glycolipid plastids according to the invention;
FIG. 6 is a diagram showing the reduction of existing color spots in the algal glycolipid plastid proposed by the present invention;
FIG. 7 is a graph of the reduction of skin aging by algal glycolipid plasmids proposed by the present invention;
FIG. 8 is a graph of the improvement of skin tone uniformity and moisturization of the algal glycolipid plastids proposed by the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
It will be understood that when an element is referred to as being "secured to" another element, it can be directly on the other element or intervening elements may also be present. When a component is referred to as being "connected" to another component, it can be directly connected to the other component or intervening components may also be present. When a component is referred to as being "disposed on" another component, it can be directly on the other component or intervening components may also be present. The terms "vertical," "horizontal," "left," "right," and the like as used herein are for illustrative purposes only.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
Example 1
Referring to fig. 1 to 8, the self-service skin rejuvenating and anti-aging cream is characterized by comprising a phase a, a phase B, a phase C, a phase D, a phase E and a phase F, wherein the phase a comprises 1 part of sucrose polystearate and cetyl palmitate, 2.5 parts of cetearyl glucoside and cetearyl alcohol, 3 parts of propylene glycol and 2 parts of cetearyl alcohol, the phase B comprises 6 parts of triglyceride, 3 parts of coco-caprylate, 2 parts of hydrogenated polyisobutene, 1 part of polydimethylsiloxane, 3 parts of shea butter, 1 part of myristyl myristate and 0.5 part of tocopherol, the phase C comprises 0.2 part of sodium polyacrylate, 4 parts of glycerol, 2 parts of butylene glycol and 5 parts of 1, 2-pentanediol, the phase D comprises 52.8 parts of deionized water and 5 parts of a moisturizing extract, the phase E comprises 0.2 part of carboxymethyl chitosan and 3 parts of deionized water, the phase F comprises 5 parts of a conditioning extract and 3 parts of deionized water, the conditioning extract comprises water, butylene glycol, trehalose, hydrogenated lecithin, carbomer, and Chondrus crispus extract.
Further, the moisturizing extract includes water, glycerin, stem extract of dendrobium stem, leaf extract of aloe vera, root extract of sophora flavescens ait, fruit extract of lycium barbarum and echinacea extract.
Further, sucrose polystearate and cetyl palmitate, cetearyl glucoside and cetearyl alcohol were used as emulsifiers in phase A.
Furthermore, the tocopherol in phase B is primarily vitamin E acting as a skin conditioner, with the remainder being emollients.
Further, deionized water in the phase D serves as a solvent to mix the moisturizing extract into the moisturizing agent.
The manufacturing process comprises the following steps:
respectively heating the S1 phase and the C A, B phase to mix, heating the C phase, adding the C phase into the A, B phase mixed solution, and fully stirring until the components are uniformly dispersed;
s2, adding the phase B into the phase A in a water bath kettle, and uniformly stirring; cooling to 55 ℃;
s3, adding the phase C into the phase A + phase B in a water bath kettle under the condition of continuously stirring, stirring and mixing uniformly, stirring and dispersing uniformly, homogenizing, and then cooling and stirring;
and S4, cooling to 40 ℃, adding the phase D, the phase E and the phase F, stirring and dispersing uniformly until the temperature is room temperature, and filling.
Further, A, B phases were mixed and heated to 80 ℃ and C phase was heated to 55 ℃.
Further, the homogenization speed of stirring in S3 was 8000, and stirring was performed for 20 min.
Example 2
Referring to fig. 1 to 8, the self-service whitening anti-aging cream is characterized by comprising a phase A, a phase B, a phase C, a phase D, a phase E and a phase F, wherein the phase A comprises 1 part of sucrose polystearate and cetyl palmitate, 2.5 parts of cetearyl glucoside and cetearyl alcohol, 3 parts of propylene glycol and 2 parts of cetearyl alcohol, the phase B comprises 6 parts of triglyceride, 3 parts of decanoate, 2 parts of hydrogenated polyisobutene, 1 part of polydimethylsiloxane, 3 parts of shea butter, 1 part of myristyl myristate and 0.5 part of tocopherol, the phase C comprises 0.2 part of sodium polyacrylate, 4 parts of glycerol, 2 parts of butanediol and 5 parts of 1, 2-pentanediol, the phase D comprises 52.8 parts of deionized water and 5 parts of a moisturizing extract, the phase E comprises 0.2 part of carboxymethyl chitosan and 3 parts of deionized water, the phase F comprises 5 parts of a conditioning extract and 3 parts of deionized water, the conditioning extract comprises water, butylene glycol, trehalose, hydrogenated lecithin, carbomer, and Chondrus crispus extract.
Further, the moisturizing extract includes water, glycerin, stem extract of dendrobium stem, leaf extract of aloe vera, root extract of sophora flavescens ait, fruit extract of lycium barbarum and echinacea extract.
Further, sucrose polystearate and cetyl palmitate, cetearyl glucoside and cetearyl alcohol were used as emulsifiers in phase A.
Furthermore, the tocopherol in phase B is primarily vitamin E acting as a skin conditioner, with the remainder being emollients.
Further, deionized water in the phase D serves as a solvent to mix the moisturizing extract into the moisturizing agent.
The manufacturing process comprises the following steps:
respectively heating the S1 phase and the C A, B phase to mix, heating the C phase, adding the C phase into the A, B phase mixed solution, and fully stirring until the components are uniformly dispersed;
s2, adding the phase B into the phase A in a water bath kettle, and uniformly stirring; cooling to 55 ℃;
s3, adding the phase C into the phase A + phase B in a water bath kettle under the condition of continuously stirring, stirring and mixing uniformly, stirring and dispersing uniformly, homogenizing, and then cooling and stirring;
and S4, cooling to 40 ℃, adding the phase D, the phase E and the phase F, stirring and dispersing uniformly until the temperature is room temperature, and filling.
Further, A, B phases were mixed and heated to 80 ℃ and C phase was heated to 55 ℃.
Further, the homogenization speed of stirring in S3 was 8000, and stirring was performed for 20 min.
As shown in fig. 2-4: comparative data for trehalose loaded liposomes vs trehalose not added liposomes
Whitening effect of seaweed glycolipid.
The seaweed glycolipid plastid has the effect of preventing skin color spots, namely reducing color spots after UV irradiation; the healing efficacy is that the existing color spots are reduced.
The clinical effect is as follows: 10 caucasian volunteers (8 females and males, average age: 44 years), applied externally applied cream containing 5% of exemriosis to the face and neck twice a day (once in the morning and evening) for 45 days, and the degree of wetting of the horny layer of the epidermis was evaluated by a skin moisturizing tester and the degree of skin color uniformity and the degree of crow's feet by a skin surface analyzer.
As shown in fig. 7 and 8, the present invention has a superior effect of removing the expression of amyloidogenic proteins on human skin, improving skin color uniformity, cuticle moisturization, fishtail size and visibility, and reducing wrinkles.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (8)
1. An autophagy whitening anti-aging cream is characterized by comprising a phase A, a phase B, a phase C, a phase D, a phase E and a phase F, wherein the phase A comprises 1 part of sucrose polystearate and cetyl palmitate, 2.5 parts of cetearyl glucoside and cetearyl alcohol, 3 parts of propylene glycol and 2 parts of cetearyl alcohol, the phase B comprises 6 parts of triglyceride, 3 parts of coco-caprylate/caprate, 2 parts of hydrogenated polyisobutene, 1 part of polydimethylsiloxane, 3 parts of shea butter, 1 part of myristyl myristate and 0.5 part of tocopherol, the phase C comprises 0.2 part of sodium polyacrylate, 4 parts of glycerol, 2 parts of butanediol and 5 parts of 1, 2-pentanediol, the phase D comprises 52.8 parts of deionized water and 5 parts of a moisturizing extract, the phase E comprises 0.2 part of carboxymethyl chitosan and 3 parts of deionized water, and the phase F comprises 5 parts of a conditioning extract and 3 parts of deionized water, the conditioning extract comprises water, butylene glycol, trehalose, hydrogenated lecithin, carbomer, and Chondrus crispus extract.
2. The autophagy rejuvenating anti-aging cream according to claim 1, wherein the moisturizing extract comprises water, glycerin, stem extract of dendrobium nobile, leaf extract of aloe barbadensis, root extract of sophora flavescens ait, fruit extract of lycium barbarum and echinacea purpurea.
3. The autophagy peel cream according to claim 1, characterized in that sucrose polystearate and cetyl palmitate, cetearyl glucoside and cetearyl alcohol of phase a are used as emulsifiers.
4. The autophagy peel anti-aging cream according to claim 1, characterized in that the tocopherol of phase B is mainly vitamin E acting as a skin conditioner, and the balance is an emollient.
5. The autophagy peel anti-aging cream according to claim 1, wherein the deionized water of phase D acts as a solvent to mix moisturizing extracts into a moisturizer.
6. The process for making an autophagy peel anti-aging cream according to any one of claims 1 to 5, comprising the steps of:
respectively heating the S1 phase and the C A, B phase to mix, heating the C phase, adding the C phase into the A, B phase mixed solution, and fully stirring until the components are uniformly dispersed;
s2, adding the phase B into the phase A in a water bath kettle, and uniformly stirring; cooling to 55 ℃;
s3, adding the phase C into the phase A + phase B in a water bath kettle under the condition of continuously stirring, stirring and mixing uniformly, stirring and dispersing uniformly, homogenizing, and then cooling and stirring;
and S4, cooling to 40 ℃, adding the phase D, the phase E and the phase F, stirring and dispersing uniformly until the temperature is room temperature, and filling.
7. The process of claim 6, wherein A, B is heated by mixing at 80 ℃ and C is heated at 55 ℃.
8. The process of claim 6, wherein the homogenization speed of the stirring in S3 is 8000, and the stirring is performed for 20 min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010438855.8A CN111588648A (en) | 2020-05-22 | 2020-05-22 | Autophagy rejuvenation anti-aging cream |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010438855.8A CN111588648A (en) | 2020-05-22 | 2020-05-22 | Autophagy rejuvenation anti-aging cream |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111588648A true CN111588648A (en) | 2020-08-28 |
Family
ID=72190624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010438855.8A Pending CN111588648A (en) | 2020-05-22 | 2020-05-22 | Autophagy rejuvenation anti-aging cream |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111588648A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112353707A (en) * | 2020-11-30 | 2021-02-12 | 重庆中佳信生物科技有限公司 | Face cream and preparation method thereof |
CN112516054A (en) * | 2020-12-30 | 2021-03-19 | 福建臻昕美生物科技有限公司 | Tea polyphenol protein cream for repairing, moisturizing and strengthening skin and production process thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060188867A1 (en) * | 2005-01-28 | 2006-08-24 | Canadian Blood Services | Method of cryopreserving cells and tissues by liposomal delivery of sugars to enhance post-thaw viability |
CN101797216A (en) * | 2010-04-27 | 2010-08-11 | 杭州三超生物科技有限公司 | Anti-freezing anti-cracking hand lotion and preparation method thereof |
WO2018173653A1 (en) * | 2017-03-24 | 2018-09-27 | 株式会社林原 | Autophagy-inducing agent and use thereof |
CN109077979A (en) * | 2018-10-24 | 2018-12-25 | 娇时日化(杭州)股份有限公司 | A kind of foster skin of essence containing various plants has both the foundation emulsion and its production technology of colour of skin adjusting |
CN109476585A (en) * | 2016-06-24 | 2019-03-15 | 因科斯医药公司 | For improving the novel autophagy activation-inducing compound of scytitis or aging |
CN109568240A (en) * | 2019-01-08 | 2019-04-05 | 上海悦目化妆品有限公司 | A kind of liquid crystal structure essence cream with humectant energy |
CN110585042A (en) * | 2019-09-30 | 2019-12-20 | 广东丸美生物技术股份有限公司 | Pearl whitening skin-care matrix and preparation method thereof |
-
2020
- 2020-05-22 CN CN202010438855.8A patent/CN111588648A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060188867A1 (en) * | 2005-01-28 | 2006-08-24 | Canadian Blood Services | Method of cryopreserving cells and tissues by liposomal delivery of sugars to enhance post-thaw viability |
CN101797216A (en) * | 2010-04-27 | 2010-08-11 | 杭州三超生物科技有限公司 | Anti-freezing anti-cracking hand lotion and preparation method thereof |
CN109476585A (en) * | 2016-06-24 | 2019-03-15 | 因科斯医药公司 | For improving the novel autophagy activation-inducing compound of scytitis or aging |
WO2018173653A1 (en) * | 2017-03-24 | 2018-09-27 | 株式会社林原 | Autophagy-inducing agent and use thereof |
CN109077979A (en) * | 2018-10-24 | 2018-12-25 | 娇时日化(杭州)股份有限公司 | A kind of foster skin of essence containing various plants has both the foundation emulsion and its production technology of colour of skin adjusting |
CN109568240A (en) * | 2019-01-08 | 2019-04-05 | 上海悦目化妆品有限公司 | A kind of liquid crystal structure essence cream with humectant energy |
CN110585042A (en) * | 2019-09-30 | 2019-12-20 | 广东丸美生物技术股份有限公司 | Pearl whitening skin-care matrix and preparation method thereof |
Non-Patent Citations (4)
Title |
---|
ELODIE METRAL等: "Autophagy as a new strategy to reduce skin pigmentation: effect of a novel cosmetic ingredient", 《CONFERENCE PAPER》 * |
ENZO EMANUELE等: "Protective effect of trehalose‑loaded liposomes against UVB‑induced photodamage in human keratinocytes", 《BIOMEDICAL REPORTS》 * |
冯清等: "《营养与美容-解开健康与美丽的奥秘》", 31 March 2013, 华中科技大学出版社 * |
陈思锋等: "《病理生理学》", 30 September 2015, 复旦大学出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112353707A (en) * | 2020-11-30 | 2021-02-12 | 重庆中佳信生物科技有限公司 | Face cream and preparation method thereof |
CN112516054A (en) * | 2020-12-30 | 2021-03-19 | 福建臻昕美生物科技有限公司 | Tea polyphenol protein cream for repairing, moisturizing and strengthening skin and production process thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111529417B (en) | Repairing eye cream with blue light resisting effect and preparation method thereof | |
CN109953926B (en) | Skin care product with five-vitamin anti-wrinkle and anti-aging effects and preparation method thereof | |
CN110623882A (en) | Whitening and freckle removing mask and preparation method thereof | |
CN111450010A (en) | Composition with anti-aging effect and application thereof in cosmetics | |
CN111557886B (en) | Plant-nourishing efficient moisturizing cream and preparation method thereof | |
CN111588648A (en) | Autophagy rejuvenation anti-aging cream | |
CN110585048B (en) | Composition with anti-saccharification and anti-oxidation functions and application thereof | |
CN110302091B (en) | Composition containing nicotinamide adenine dinucleotide for resisting skin aging and preparation method and application thereof | |
CN110179730B (en) | Repair cream | |
CN111686068A (en) | Anti-wrinkle skin-activating cream and preparation method thereof | |
CN113332212A (en) | Whitening composition and preparation method and application thereof | |
CN115154375B (en) | Stable cleaning composition with repairing and relieving effects | |
US4593038A (en) | Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation | |
CN107115347B (en) | Liposome antiallergic agent and cosmetic for repairing hormone-dependent dermatitis | |
CN111991286A (en) | Eye cream composition for fading fine wrinkles and preparation method thereof | |
CN111973486A (en) | Ceramide moisturizing and moisture-keeping cream and preparation method thereof | |
CN113648257A (en) | Whitening and freckle-removing composition and preparation method and application thereof | |
CN107898734B (en) | Application of agave extract in preparing external itching-relieving and moisturizing personal care product | |
CN112972325A (en) | Air-sensitive face cream containing plant active ingredients and preparation method thereof | |
CN108451806A (en) | A kind of natural antiallergic moisture-keeping composition and its preparation method and application | |
ES2976990T3 (en) | Using an extract of Bixa orellana | |
CN111728891A (en) | Acne mark removing composition and application thereof | |
CN115737451A (en) | Alpha-gel composition, cosmetic and preparation method thereof | |
CN118524828A (en) | Sebum production inhibitor/promoter | |
CN108703926B (en) | Whitening, moisturizing, firming and anti-wrinkle face cream and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200828 |
|
RJ01 | Rejection of invention patent application after publication |